Page last updated: 2024-10-14

nnz 2566

Description

NNZ 2566: an (1-3) IGF-1 analog with neuroprotective activity [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11318905
CHEMBL ID197084
SCHEMBL ID1170014
MeSH IDM0535262

Synonyms (36)

Synonym
trofinetide
acp-2566
nnz-2566
CHEMBL197084
glycyl-l-2-methylprolyl-l-glutamic acid
who 10076
unii-z2me8f52ql
853400-76-7
nnz 2566
z2me8f52ql ,
trofinetide [inn]
l-glutamic acid, glycyl-2-methyl-l-prolyl-
trofinetide [usan:inn]
trofinetide [usan]
SCHEMBL1170014
trofinetide [who-dd]
daybue
glycyl-2-methyl-l-prolyl-l-glutamic acid
trofinetide(nnz2566)
AKOS030607026
CS-8154
((s)-1-glycyl-2-methylpyrrolidine-2-carbonyl)-l-glutamic acid
HY-16757
DB06045
Q27294917
MS-24628
(2s)-2-[[(2s)-1-(2-aminoacetyl)-2-methylpyrrolidine-2-carbonyl]amino]pentanedioic acid
DTXSID101336041
gtpl12482
analogue 4 [pmid: 15837309]
nnz2566
glycyl-alpha-methyl-l-prolyl-l-glutamic acid
AT37725
trofinetidum
trofinetida
EX-A7815

Pharmacokinetics

ExcerptReference
" A meta-analytical approach was used to analyse pharmacokinetic data from 3 different studies, in which a total of 61 healthy subjects (median age: 23years, range: 19 to 38) were treated with NNZ-2566."( Population pharmacokinetics of NNZ-2566 in healthy subjects.
Della Pasqua, O; Glass, L; Horrigan, J; Jones, N; Oosterholt, SP, 2017
)
" Food can affect the pharmacokinetic profile of a drug, and this phase 1 study assessed the potential effect of food on the pharmacokinetics of trofinetide."( A Phase 1, Open-Label Study to Evaluate the Effects of Food and Evening Dosing on the Pharmacokinetics of Oral Trofinetide in Healthy Adult Subjects.
Darwish, M; DeKarske, D; Harlick, J; Stankovic, S; Youakim, JM, 2022
)
" Blood and urine samples were collected at scheduled timepoints for trofinetide pharmacokinetic analysis."( A Phase 1, Open-Label Study to Evaluate the Effects of Food and Evening Dosing on the Pharmacokinetics of Oral Trofinetide in Healthy Adult Subjects.
Darwish, M; DeKarske, D; Harlick, J; Stankovic, S; Youakim, JM, 2022
)

Bioavailability

ExcerptReference
" NNZ-2566 is a structural analogue of Glypromate, resulting from alpha-methylation of the proline moiety, which has improved the elimination half-life and oral bioavailability over the parent peptide."( NNZ-2566: a Gly-Pro-Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke.
Batchelor, DC; Bickerdike, MJ; Brimble, MA; Gluckman, PD; Harris, PW; Leong, W; Lin, H; Sieg, F; Sirimanne, ES; Thomas, GB; Wen, J, 2009
)
" In addition, oral bioavailability appeared to vary with food intake."( Population pharmacokinetics of NNZ-2566 in healthy subjects.
Della Pasqua, O; Glass, L; Horrigan, J; Jones, N; Oosterholt, SP, 2017
)
" The study also evaluated the potential effect of evening dosing on trofinetide bioavailability and characterized the pharmacokinetic profile of trofinetide in urine."( A Phase 1, Open-Label Study to Evaluate the Effects of Food and Evening Dosing on the Pharmacokinetics of Oral Trofinetide in Healthy Adult Subjects.
Darwish, M; DeKarske, D; Harlick, J; Stankovic, S; Youakim, JM, 2022
)

Dosage Studied

ExcerptReference
" In the initial dose-response experiments, NNZ-2566 (0."( NNZ-2566, a glypromate analog, improves functional recovery and attenuates apoptosis and inflammation in a rat model of penetrating ballistic-type brain injury.
Chen, RW; Dave, JR; Liao, Z; Lu, XC; Tortella, FC; Wei, H; Yang, X; Yao, C, 2009
)
" The study also evaluated the potential effect of evening dosing on trofinetide bioavailability and characterized the pharmacokinetic profile of trofinetide in urine."( A Phase 1, Open-Label Study to Evaluate the Effects of Food and Evening Dosing on the Pharmacokinetics of Oral Trofinetide in Healthy Adult Subjects.
Darwish, M; DeKarske, D; Harlick, J; Stankovic, S; Youakim, JM, 2022
)
"A 60 mL oral solution of trofinetide (12 g) was administered in three dosing periods: morning fasted (A; reference), morning fed (B), and evening fasted (C)."( A Phase 1, Open-Label Study to Evaluate the Effects of Food and Evening Dosing on the Pharmacokinetics of Oral Trofinetide in Healthy Adult Subjects.
Darwish, M; DeKarske, D; Harlick, J; Stankovic, S; Youakim, JM, 2022
)
"This study supports dosing of trofinetide without regard to food."( A Phase 1, Open-Label Study to Evaluate the Effects of Food and Evening Dosing on the Pharmacokinetics of Oral Trofinetide in Healthy Adult Subjects.
Darwish, M; DeKarske, D; Harlick, J; Stankovic, S; Youakim, JM, 2022
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (1)

PathwayProteinsCompounds
MECP2 and associated Rett syndrome011

Bioassays (2)

Assay IDTitleYearJournalArticle
AID239119Displacement of L-[3H]glutamate from N-methyl-D-aspartate glutamate receptor in rat brain synaptic membranes2005Bioorganic & medicinal chemistry letters, May-02, Volume: 15, Issue:9
Analogues of the neuroprotective tripeptide Gly-Pro-Glu (GPE): synthesis and structure-activity relationships.
AID267563Displacement of L[3H]glutamate from GluR in rat brain synaptic membrane2006Bioorganic & medicinal chemistry letters, Jul-01, Volume: 16, Issue:13
The neuroprotective activity of GPE tripeptide analogues does not correlate with glutamate receptor binding affinity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (31.58)29.6817
2010's5 (26.32)24.3611
2020's8 (42.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials7 (36.84%)5.53%
Reviews1 (5.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (57.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]